These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34668328)

  • 1. Trajectory mapping of primary Sjögren's syndrome via transcriptome learning demonstrates limitations of peripheral blood sequencing.
    Zhong B; Wang Y; Zou Q; Xuemeng C; Qian C; Chen C; Xiong J; Zheng Z; Zou L; Li J
    Int J Rheum Dis; 2021 Dec; 24(12):1491-1499. PubMed ID: 34668328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
    Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
    Front Immunol; 2021; 12():681941. PubMed ID: 34295332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of epithelium-associated FcRL4
    Verstappen GM; Ice JA; Bootsma H; Pringle S; Haacke EA; de Lange K; van der Vries GB; Hickey P; Vissink A; Spijkervet FKL; Lessard CJ; Kroese FGM
    J Autoimmun; 2020 May; 109():102439. PubMed ID: 32201227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the key genes and pathways involved in B cells in primary Sjögren' s syndrome.
    Lei S; Zhang Y
    Bioengineered; 2021 Dec; 12(1):2055-2073. PubMed ID: 34034637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
    Shi L; Fu Q; Chen N; Liu R; Zheng Y
    Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic myocardial dysfunction was revealed by feature tracking cardiac magnetic resonance imaging in patients with primary Sjögren's syndrome.
    Yokoe I; Kobayashi H; Nishiwaki A; Nagasawa Y; Kitamura N; Haraoka M; Kobayashi Y; Takei M; Nakamura H
    Int J Rheum Dis; 2021 Dec; 24(12):1482-1490. PubMed ID: 34694689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment.
    Both T; Dalm VA; van Hagen PM; van Daele PL
    Int J Med Sci; 2017; 14(3):191-200. PubMed ID: 28367079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome.
    Baldini C; Rossi C; Ferro F; Santini E; Seccia V; Donati V; Solini A
    J Intern Med; 2013 Nov; 274(5):480-9. PubMed ID: 23906036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed genes in primary Sjögren's syndrome.
    Zhang L; Xu P; Wang X; Zhang Z; Zhao W; Li Z; Yang G; Liu P
    J Cell Biochem; 2019 Oct; 120(10):17368-17377. PubMed ID: 31125139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
    Imgenberg-Kreuz J; Sandling JK; Almlöf JC; Nordlund J; Signér L; Norheim KB; Omdal R; Rönnblom L; Eloranta ML; Syvänen AC; Nordmark G
    Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
    Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
    Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic T cells in primary Sjögren's syndrome: a double-edged sword?
    Alunno A; Ibba-Manneschi L; Bistoni O; Cipriani S; Topini F; Gerli R; Manetti M
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):36-41. PubMed ID: 30336792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
    Blokland SLM; van den Hoogen LL; Leijten EFA; Hartgring SAY; Fritsch R; Kruize AA; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2019 Oct; 58(10):1740-1745. PubMed ID: 31220315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Interferons in the Pathogenesis of Sjögren's Syndrome and Future Therapeutic Perspectives.
    Del Papa N; Minniti A; Lorini M; Carbonelli V; Maglione W; Pignataro F; Montano N; Caporali R; Vitali C
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33572487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA and mRNA expression profile of peripheral blood mononuclear cells in primary Sjögren's syndrome patients.
    Peng Y; Luo X; Chen Y; Peng L; Deng C; Fei Y; Zhang W; Zhao Y
    Sci Rep; 2020 Nov; 10(1):19629. PubMed ID: 33184486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullary response to glucagon in patients with primary Sjögren's syndrome.
    Imrich R; Nikolov NP; Bebris L; Alevizos I; Goldstein DS; Holmes CS; Illei GG
    Cell Mol Neurobiol; 2012 Jul; 32(5):903-6. PubMed ID: 22350211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.